Home
Focus & approach
Dare
Build
Criteria
Portfolio
Team & Partners
Team Investment Management
Advisory board
Partners
vacancies
News & Events
News
Media
Events
Impact & ESG
Impact & ESG
impact Committee
Contact

Thuja

Home
Focus & approach
Dare
Build
Criteria
Portfolio
Team & Partners
Team Investment Management
Advisory board
Partners
vacancies
News & Events
News
Media
Events
Impact & ESG
Impact & ESG
impact Committee
Contact
Tim Van Hauwermeiren, a ‘Lucky Luke' of 14 billion
February 8, 2021
Aartie Nanda
Tim Van Hauwermeiren, a ‘Lucky Luke' of 14 billion
Aartie Nanda
February 8, 2021

Tim Van Hauwermeiren, a ‘Lucky Luke' of 14 billion

Aartie Nanda
February 8, 2021

Nice article in the Belgian business newspaper “De Tijd”: how a great team with a good idea created one of the largest biotech success stories in the Benelux, and the important role of Thuja Capital igniting it.

Please note: the article in Dutch language.

https://www.tijd.be/ondernemen/farma-biotech/tim-van-hauwermeiren-een-lucky-luke-van-14-miljard/10282506.html


Newer PostIndigo Diabetes Initiates First Clinical Study of its Continuous Glucose Monitoring Sensor
Older PostReuma Nederland supports further development of synthetic meniscus from ATRO Medical

Subscribe to our newsletter

By subscribing to our newsletter, you agree to the storage of your contact details. We value your privacy and will take great care to keep your information secure.

Thank you!

Back to Top

Thuja Capital Management BV
LSI Buidling | Yalelaan 62

3584 CM Utrecht
The Netherlands